KOLMAR-HOLDINGS
Kolmar Korea (KRX: 161890) joins forces with Amazon, the world's leading e-commerce platform, to support the successful global market entry of K-beauty brands.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240708461379/en/
Sang-hyun Yoon, Vice President of Kolmar Group, delivers welcoming remark at the Amazon K-Beauty Conference Seller Day (Image: Kolmar Korea)
Kolmar Korea announced that it has jointly hosted the 'Amazon K-Beauty Conference Seller Day' with Amazon on June 27 at the InterContinental Hotel in Seoul.
The event was attended by about 1,500 individuals, including officials from Korean beauty brands as well as those from the distribution and manufacturing sectors, both online and offline. Key attendees included Sang-hyun Yoon, Vice President of Kolmar Group; Hyun-gyu Choi, CEO of Kolmar Korea; Jim Yang, Executive Vice President of Amazon Global Selling Asia Pacific (APAC); and Yuki Suita, Head of Consumer Beauty Business at Amazon Japan.
In his welcome speech, Sang-hyun Yoon explained the event's purpose. He said, “This event, organized by Kolmar and Amazon, is more than just a business partnership. It aims to spread the innovation and value of K-beauty globally. We hope this event will be a cornerstone in exploring global opportunities for K-beauty and sharing detailed strategies for implementation.”
The event came as K-beauty is gaining a great popularity on Amazon, and both companies want to actively support Korean beauty companies’ entry into the global market.
K-beauty is so popular that sales of K-beauty products on Amazon's global store rose more than 75% last year. Kolmar Korea is leading this trend by securing new contracts with 253 customers, predominantly indie brands, marking a 48.7% increase from the previous year. The two companies plan to keep identifying standout brands that drive global market trends with compelling concepts and innovative technologies.
At the event, Kolmar Korea established a large-scale booth showcasing skin care, makeup, sun care, and cosmetic packages. They also provided customized consultations for the global cosmetics business. Moreover, Sang-Keun Han, Vice Director of Kolmar Korea R&D Complex, delivered a lecture titled ‘Deeply Grounded Confidence: The Competitiveness of Korean Cosmetics.’
A representative from Kolmar Korea said, “This event is significant as it marks the inaugural collaboration between Kolmar Korea, a global cosmetics ODM company that has driven the growth of K-beauty, and Amazon, the world’s largest e-commerce company. Kolmar and Amazon will pursue shared growth by offering the optimal pathway to support our customers’ successful entry into global markets.”
Event highlights video: https://www.youtube.com/watch?v=sbqXL8fBgpM
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240708461379/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release
MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,
FieldBee Vision wins Gold for Digital Technology Innovation at LAMMA 20269.1.2026 05:25:00 CET | Press release
FieldBee, the European leader in high-quality, easy-to-use and affordable precision agriculture technologies, proudly announces that FieldBee Vision has earned global recognition, becoming the Gold Winner in the Digital Technology Innovation of the Year category at the LAMMA Innovation Awards 2026. Lamma Show is the UK’s premier agricultural machinery, technology and equipment innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260107606411/en/ FieldBee wins the LAMMA Innovation Award 2026 for Digital Technology Innovation of the Year for the FieldBee Vision (VisionSteer & VisionPro) system FieldBee Vision is part of the newly launched myFieldBee ecosystem, built to unify FieldBee’s precision farming tools and designed to connect navigation, autosteering, ISOBUS into one unified platform that supports planning, execution, monitoring and reporting. FieldBee Vision, the first modular retrofit agricultural vision system,
Survey Finds Over 70% of Chinese Doctors Recommend “AI Doctor Services” Like Ant Group’s AQ for Everyday Health Needs9.1.2026 04:31:00 CET | Press release
A recent survey by Life Times, a well-known Chinese public health media outlet, shows that AI doctor services are broadly supported by doctors in China. Among 500 physicians from the country’s top-tier (tertiary) hospitals, more than 70% said they would recommend AI doctor services to patients for everyday health questions and routine health management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108456917/en/ Ant Group’s AI-native health app AQ is designed to address common, everyday health concerns and support healthy habit formation. Ant Group’s AQ was the most frequently recommended platform in the survey. The latest figures show that, as of January 2026, the app had accumulated 30 million monthly active users and answers over 10 million health-related questions daily, making it China’s leading AI-native health app. AQ—known in Chinese as Ant A-Fu—is an AI-native health app launched by Ant Group in June 2025. Desig
OPPO Joins VVC Advance Patent Pool as a Licensee and Extends HEVC Advance License9.1.2026 03:00:00 CET | Press release
Access Advance LLC and Guangdong OPPO Mobile Telecommunications Corp., Ltd. (OPPO) today announced that OPPO has joined the VVC Advance Patent Pool as a Licensee and renewed its HEVC Advance License. OPPO, one of the world's largest smartphone manufacturers with operations in more than 70 countries, has been a valued participant in Access Advance's HEVC patent pool since 2020, and more recently joined the Advance Video Distribution Patent (VDP) Pool as a Licensor. These latest agreements mark a new milestone in a broad and deepening relationship between the two companies, with OPPO now participating across all three of Access Advance's video codec licensing programs. The VVC Advance Patent Pool licenses patents essential to the VVC/H.266 standard, which delivers remarkable improvement of video compression performance over HEVC, enabling higher-quality video experiences including 4K, 8K, and HDR content with faster downloads and lower latency. The pool currently includes over 4,500 worl
Cessna Citation CJ3 Gen2 Enters Into Service, Delivering the Most Significant Gen2 Updates to Date8.1.2026 22:30:00 CET | Press release
The Cessna Citation CJ3 Gen2 has entered into service, setting a new standard for the Citation Gen2 family. Launch customers and longtime Citation owners Dave Mecartney and Shannon Day took delivery of their new aircraft this week. Mecartney—an experienced aviator with nearly two decades flying Citation light jets and a member of Textron Aviation’s Customer Advisory Board—helped shape the enhancements that elevate the CJ3 Gen2 experience. Key upgrades include Garmin autothrottle technology, added pilot legroom and a fully customizable cabin environment, all driven by customer feedback. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108455097/en/ Cessna Citation CJ3 Gen2 enters into service, delivering the most significant Gen2 updates to date (Photo credit: Textron Aviation). The Cessna Citation CJ3 Gen2 is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company. “The Citation CJ3 Gen2 deliv
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom